{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:39:12Z","timestamp":1648535952027},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taichung Veterans Hospital","award":["TCVGH-1023606C"],"award-info":[{"award-number":["TCVGH-1023606C"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.transproceed.2018.02.181","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T01:05:39Z","timestamp":1521507939000},"page":"2398-2400","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Significance of Serum Visfatin in Renal Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"K.-H.","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-F.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.-M.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.02.181_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.181_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.smim.2011.08.021","article-title":"Humoral immunity and antibody-mediated rejection in solid organ transplantation","volume":"23","author":"Montgomery","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.transproceed.2018.02.181_bib3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.transproceed.2018.02.181_bib4","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2018.02.181_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2008.10.004","article-title":"Nampt: linking NAD biology, metabolism and cancer","volume":"20","author":"Garten","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2018.02.181_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cytogfr.2013.05.006","article-title":"Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions","volume":"24","author":"Sun","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.transproceed.2018.02.181_bib7","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.181.7.4685","article-title":"Nicotinamide phosphoribosyl transferase\/pre-B cell colony-enhancing factor\/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress","volume":"181","author":"Rongvaux","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"1 Suppl","key":"10.1016\/j.transproceed.2018.02.181_bib8","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00007890-200201151-00009","article-title":"Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models","volume":"73","author":"Jonker","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.181_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ni.3054","article-title":"Pathophysiology of T follicular helper cells in human and mice","volume":"16","author":"Ueno","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.transproceed.2018.02.181_bib10","first-page":"166","article-title":"Muscle and fat metabolism in obesity after kidney transplantation: no effect of peritoneal dialysis or hemodialysis","volume":"22","author":"Teplan","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.transproceed.2018.02.181_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.transproceed.2013.11.031","article-title":"Short-term prospective study of metabolic syndrome in renal transplant recipients","volume":"46","author":"Shu","year":"2014","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518304445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518304445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T05:25:59Z","timestamp":1539235559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518304445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0041134518304445"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.181","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Significance of Serum Visfatin in Renal Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}